Literature DB >> 3972805

Salvage of circulating pyrimidine nucleosides by tissues of the mouse.

J D Moyer, N Malinowski, O Ayers.   

Abstract

The metabolism of pyrimidine nucleosides present in the plasma of the mouse has been examined. Uridine and cytidine are rapidly cleared from the circulation with t1/2 of less than 5 min. Uracil, deoxycytidine, deoxyuridine, and thymidine are cleared more slowly with t1/2 of 9 to 13 min. Various tissues differed markedly in the extent of nucleotide formation from circulating nucleosides. Cytidine and uridine are predominantly converted to nucleotides (greater than 50%) rather than catabolized, whereas uracil is almost entirely degraded. Thymidine, deoxyuridine, and deoxycytidine are intermediate in the extent of their conversion to nucleotides: 8.9 to 21% of these nucleosides are salvaged in the mouse. Both anabolic and catabolic routes are important in the metabolism of pyrimidine nucleosides in vivo.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Microarray analysis of newly synthesized RNA in cells and animals.

Authors:  M Kenzelmann; S Maertens; M Hergenhahn; S Kueffer; A Hotz-Wagenblatt; L Li; S Wang; C Ittrich; T Lemberger; R Arribas; S Jonnakuty; M C Hollstein; W Schmid; N Gretz; H J Gröne; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

2.  Changes in 2'-deoxycytidine levels in various tissues of tumor-bearing mice.

Authors:  Ayano Iwazaki; Kimie Imai; Kunio Nakanishi; Masanori Yoshioka
Journal:  Oncol Lett       Date:  2010-09-08       Impact factor: 2.967

3.  Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.

Authors:  P K Rathod; A Khatri; T Hubbert; W K Milhous
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.

Authors:  Koji Kato; Haruyuki Mori; Tomoko Kito; Miyu Yokochi; Sumito Ito; Katsuhisa Inoue; Atsushi Yonezawa; Toshiya Katsura; Yuji Kumagai; Hiroaki Yuasa; Yoshinori Moriyama; Ken-ichi Inui; Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2013-08-02       Impact factor: 4.200

5.  Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice.

Authors:  Z M Gómez; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

6.  Pyrimidine metabolism and sugar nucleotide synthesis in rat liver.

Authors:  W R Pels Rijcken; G J Hooghwinkel; W Ferwerda
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

7.  Comparison of the bioavailability of uridine in mice after either oral or parenteral administration.

Authors:  P Klubes; D B Geffen; R L Cysyk
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Trypanosoma brucei (UMP synthase null mutants) are avirulent in mice, but recover virulence upon prolonged culture in vitro while retaining pyrimidine auxotrophy.

Authors:  Han B Ong; Natasha Sienkiewicz; Susan Wyllie; Stephen Patterson; Alan H Fairlamb
Journal:  Mol Microbiol       Date:  2013-09-09       Impact factor: 3.501

9.  ADME studies of [5-(3)H]-2'-O-methyluridine nucleoside in mice: a building block in siRNA therapeutics.

Authors:  Frederic Lozac'h; Jesper Christensen; Thomas Faller; Esther van de Kerkhof; Joel Krauser; Maxime Garnier; Karine Litherland; Alexandre Catoire; Francois Natt; Jurg Hunziker; Piet Swart
Journal:  Pharmacol Res Perspect       Date:  2016-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.